BioMarin Pharmaceuticals BMRN Operating margin

Operating margin at other companies

PTC TherapeuticsPTCT

1.6%-38.7pp

Zevra Therapeutics, Inc.ZVRA

-103.9%-43.0pp

Agios PharmaceuticalsAGIO

-466.8%-173pp

RegenxbioRGNX

-94.1%-9.3pp

BridgeBio PharmaBBIO

-90.5%-41.2pp

Crinetics PharmaceuticalsCRNX

-3,020.3%-1,463pp

FAQ

What is BioMarin Pharmaceuticals's operating margin?

BioMarin Pharmaceuticals (BMRN) reported operating margin of 19.9% in Q3 2025.

How has BioMarin Pharmaceuticals's operating margin changed year-over-year?

BioMarin Pharmaceuticals's operating margin increased by 56.4% year-over-year, from 12.7% to 19.9%.

What is the long-term trend for BioMarin Pharmaceuticals's operating margin?

Over 4 years (2020 to 2024), BioMarin Pharmaceuticals's operating margin has grown at a 64.2% compound annual growth rate (CAGR), from -2.3% to 17%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.